Compugen Stock

Compugen Current Ratio

The Current Ratio of Compugen (CGEN) as of Sep 4, 2026 is 7.09. In the previous year, Current Ratio was 5.52 — a change of 28.48% (higher).

Current Ratio

7.09

YoY

28.48%

Last updated:

Current Ratio of Compugen is 2026 7.09 . Current Ratio of Compugen was 2025 5.52 . It decreases by 28.48% higher compared to the previous year.
Access this data via the Eulerpool API

Compugen Stock analysis

What does Compugen do? Compugen Ltd is an Israeli biotechnology company focused on the development of therapeutics and diagnostic products. It was founded in 1993 and is headquartered in Tel Aviv. Compugen is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Compugen stock

Current Ratio of Compugen is 7.09 in 2026.

Current Ratio of Compugen changed from 5.52 to 7.09, representing a 28.48% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Current Ratio Compugen since 2006 – with annual values, charts, and detailed analysis.

The Current Ratio measures a company's ability to pay short-term obligations. A ratio above 1 indicates that current assets exceed current liabilities.

Current Ratio = Current Assets / Current Liabilities

A 'good' varies by industry and company stage. On Eulerpool, you can compare Current Ratio's Compugen with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Leverage — Compugen

All Key Metrics — Compugen